SCHEMBL8846296

SCHEMBL8846296

O=C(O)C(O)(C1CCCCC1)C(O)(C(=O)O)C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
EPHX1 P07099 7/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP3A4 P08684 1/20 0.33
EPHX2 P34913 1/20 0.33
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
SSTR4 P31391 1/20 0.32
GRM2 Q14416 1/20 0.32
GRM3 Q14832 1/20 0.32
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15346128 0.87 EPHX1 (0.50) KEAP1NFE2L2EPHX1NPC1SMN1; SMN2
SCHEMBL29037985 0.86 KEAP1 (0.40) KEAP1NFE2L2CES2CES1ALDH1A1
SCHEMBL30031136 0.86 KEAP1 (0.40) KEAP1NFE2L2CES2CES1NPC1
SCHEMBL66869 0.79 KEAP1 (0.45) KEAP1NFE2L2CES2CES1EPHX1
SCHEMBL28038044 0.78 PDK1 (0.38) KEAP1NFE2L2EPHX1NPC1RAB9A
SCHEMBL9432704 0.77 KEAP1 (0.34) KEAP1NFE2L2NPC1RAB9ASMN1; SMN2
SCHEMBL2846765 0.76 KEAP1 (0.42) KEAP1NFE2L2CES2CES1EPHX1
SCHEMBL8328164 0.76 KEAP1 (0.42) KEAP1NFE2L2CES2CES1EPHX1
SCHEMBL873007 0.76 KEAP1 (0.42) KEAP1NFE2L2CES2CES1EPHX1
SCHEMBL13518672 0.75 EPHX1 (0.42) CES2EPHX1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778069-B2 Phase change inks containing oligomeric rosin esters XEROX CORPORATION (US) 2014-07-15 US claimed
US-20140137767-A1 Phase Change Inks Containing Oligomeric Rosin Esters XEROX CORPORATION (US) 2014-05-22 US claimed
US-5432273-A Cyclizing a 5-(protected)oxy-5-(heterocyclic base)-3(S)-fluoro-1,2-(S)-pentanediol EMORY UNIVERSITY (US) 1995-07-11 US claimed
US-5414078-A Preparation of 3'-substituted-2',3'-dideoxynucleosides and 2'-deoxynucleosides from acyclic, achiral precursors EMORY UNIVERSITY (US) 1995-05-09 US claimed
WO-1992017485-A1 PREPARATION OF 3'-SUBSTITUTED-2',3'-DIDEOXYNUCLEOSIDES AND 2'-DEOXYNUCLEOSIDES FROM ACYCLIC, ACHIRAL PRECURSORS EMORY UNIVERSITY (US) 1992-10-15 WO claimed
EP-2933246-B1 VERSATILE AND FUNCTIONALISED INTERMEDIATES FOR THE SYNTHESIS OF VITAMIN D AND NOVEL VITAMIN D DERIVATIVES ENDOTHERM GMBH (DE) 2020-01-08 EP disclosed
US-20190103634-A1 Electrolyte for Lithium Secondary Battery and Lithium Secondary Battery Containing the Same SK INNOVATION CO., LTD. (KR) 2019-04-04 US disclosed
US-9994508-B2 Versatile and functionalised intermediates for the synthesis of vitamin D and novel vitamin D derivatives ENDOTHERM GMBH (DE) 2018-06-12 US disclosed
CN-105428713-A Electrolyte for Lithium Secondary Battery and Lithium Secondary Battery Containing the Same SK INNOVATION CO LTD 2016-03-23 CN disclosed
US-20160079627-A1 Electrolyte for Lithium Secondary Battery and Lithium Secondary Battery Containing the Same SK INNOVATION CO., LTD. (KR) 2016-03-17 US disclosed
CN-105406126-A Electrolyte For Lithium Secondary Battery And Lithium Secondary Battery Containing The Same SK INNOVATION CO LTD 2016-03-16 CN disclosed
US-20160072150-A1 Electrolyte for Lithium Secondary Battery and Lithium Secondary Battery Containing the Same SK INNOVATION CO., LTD. (KR) 2016-03-10 US disclosed
EP-0630361-A4 PALLADIUM CATALYZED ALKYLATIVE CYCLIZATION USEFUL IN SYNTHESIS OF VITAMIN D AND ANALOGUES. UNIV LELAND STANFORD JUNIOR (US) 1995-08-23 EP disclosed
US-5432273-A Cyclizing a 5-(protected)oxy-5-(heterocyclic base)-3(S)-fluoro-1,2-(S)-pentanediol EMORY UNIVERSITY (US) 1995-07-11 US disclosed
WO-1995017363-A1 PALLADIUM CATALYZED ALKYLATIVE CYCLIZATION USEFUL IN SYNTHESES OF VITAMIN D AND ANALOGUES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 1995-06-29 WO disclosed
US-5414078-A Preparation of 3'-substituted-2',3'-dideoxynucleosides and 2'-deoxynucleosides from acyclic, achiral precursors EMORY UNIVERSITY (US) 1995-05-09 US disclosed
EP-0630361-A1 PALLADIUM CATALYZED ALKYLATIVE CYCLIZATION USEFUL IN SYNTHESIS OF VITAMIN D AND ANALOGUES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 1994-12-28 EP disclosed
US-5292977-A Palladium catalyzed alkylative cyclization useful in synthesis of vitamin D and analogues BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY (US) 1994-03-08 US disclosed
WO-1993016022-A1 PALLADIUM CATALYZED ALKYLATIVE CYCLIZATION USEFUL IN SYNTHESIS OF VITAMIN D AND ANALOGUES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 1993-08-19 WO disclosed
WO-1992017485-A1 PREPARATION OF 3'-SUBSTITUTED-2',3'-DIDEOXYNUCLEOSIDES AND 2'-DEOXYNUCLEOSIDES FROM ACYCLIC, ACHIRAL PRECURSORS EMORY UNIVERSITY (US) 1992-10-15 WO disclosed